A case report demonstrated M. chelonae skin and soft tissue infection in a patient with chronic lymphocytic leukemia (LLC) who was using ibrutinib, an oral drug, which acts by inhibiting Bruton tyrosine kinase (BTK) for the treatment of various malignant B-cell diseases (173, 174). The gene discussed is BTK; the disease is B-cell chronic lymphocytic leukemia.